Brazil is widely recognized as the largest healthcare market in Latin America and one of the most promising destinations for global medical device manufacturers. With a complex regulatory framework and strong demand for innovative technologies, the country offers significant opportunities but also requires a structured approach to market entry.  One of the most effective strategies for international companies seeking to enter the Brazilian market is regulatory hosting, a model that enables manufacturers to operate locally without the need to establish a subsidiary or build a full regulatory and operational structure from scratch.  At Brisa, regulatory hosting is more than an administrative service. It is a strategic gateway that allows global manufacturers to access the Brazilian healthcare ecosystem with agility, compliance, and commercial readiness.  Understanding Regulatory Hosting in Brazil  In Brazil, medical devices must be registered or notified with the national regulatory authority, the Agência Nacional de Vigilância Sanitária (ANVISA). To complete this process, foreign manufacturers must appoint a Brazilian Registration Holder (BRH), a locally established entity legally responsible for the product registration and its compliance with Brazilian regulations.  Regulatory hosting is the model through which a qualified Brazilian partner assumes this role on behalf of the manufacturer. This structure allows international companies to:  However, the effectiveness of this model depends heavily on the quality, governance, and strategic vision of the hosting partner.  Beyond Compliance: The Strategic Value of Regulatory Hosting  While regulatory hosting is often perceived as a legal requirement, in practice it can become a powerful business accelerator when managed strategically. A specialized partner can help manufacturers:  The Brisa Model: Regulatory Hosting Within an Integrated Ecosystem  What differentiates Brisa is that regulatory hosting is not offered in isolation. Instead, it is part of an integrated ecosystem that connects regulatory strategy, market access, purchasing networks, and distribution capabilities. This model enables manufacturers to move seamlessly from regulatory approval to commercial execution.  Within the Brisa ecosystem, regulatory hosting connects directly with:  This integrated approach reduces fragmentation and eliminates the need to coordinate multiple independent partners across the regulatory and commercial journey. For global manufacturers, the result is a simpler, faster, and more secure entry into the Brazilian healthcare market.  A Strategic Bridge Between Innovation and Market Access  Brazil’s healthcare system continues to evolve rapidly, driven by technological innovation, demographic shifts, and increasing demand for advanced medical solutions. In this environment, regulatory hosting becomes more than a compliance mechanism; it becomes a strategic bridge between global innovation and local healthcare delivery.  By combining regulatory expertise with operational and commercial capabilities, Brisa helps manufacturers transform regulatory approval into real market presence. Because entering a new market should not be defined by complexity, but by opportunity.  Find out more about BPO in RA!   *Budget for registration ownership transfer, Market Access Strategy, and BPO in RA services for your company: www.brisa.com.br  

When Time Equals Value: How Efficient Regulation Drives Innovation and Growth  In healthcare, every regulatory decision carries economic weight. From the moment a medical device begins its approval process to the point it reaches the market, time, cost, and opportunity are inseparably linked. Efficient regulatory systems not only protect patients but they also stimulate innovation, attract investment, and strengthen competitiveness.  At Brisa, we see regulatory efficiency as both a public health priority and a strategic economic driver for the medical device industry.  1. The Economics of Time to Market  For medical device manufacturers, time to market is one of the most critical business metrics. Every month of delay in regulatory approval can mean postponed revenue, missed hospital procurement cycles, and delayed access for patients. Studies show that reducing approval timelines while maintaining quality and safety directly translates into:  Faster return on investment (ROI);  Lower operational costs;  Earlier feedback from real-world use;  Stronger reinvestment capacity for R&D.  In emerging markets like Brazil, where healthcare demand is growing rapidly, shortening this journey without compromising rigor creates a win-win scenario for companies, regulators, and patients alike.  2. Regulation as an Economic Enabler  Regulation is often viewed as a cost center but when well-structured, it becomes a growth catalyst. By providing predictability, transparency, and risk-based oversight, regulatory efficiency enables companies to plan and invest with confidence. Efficient frameworks also improve national competitiveness.  Countries that streamline regulatory processes tend to:  Attract more foreign manufacturers seeking stable market conditions;  Stimulate local innovation by reducing administrative barriers;  Enhance public health outcomes, which in turn drive productivity and social development.  In this sense, regulatory efficiency is not just good governance; it is economic strategy.  3. The Brazilian Context: Progress Through Modernization  Over the past decade, Anvisa has made significant progress toward modernization. Initiatives such as digital submissions, harmonization with the International Medical Device Regulators Forum, and risk-based evaluations have increased transparency and reduced bureaucracy.  Resolutions like RDC 751/2022 which redefined the classification and registration of medical devices are evidence of this evolution. These reforms have improved alignment with international standards while maintaining Brazil’s high level of regulatory rigor. The result is faster approvals, stronger oversight, and a growing reputation for regulatory reliability in Latin America.  4. How Brisa Creates Economic Value Through Regulatory Strategy  At Brisa, we help manufacturers capture the full economic potential of efficient regulation. Our integrated ecosystem combines technical expertise, data-driven analysis, and operational agility to reduce delays, avoid rework, and optimize cost across the entire regulatory lifecycle.  We support our clients by:  Designing efficient registration strategies based on product risk and market goals;  Anticipating and adapting to Anvisa’s evolving requirements;  Streamlining documentation and technical justification;  Managing renewals, post-market surveillance, and quality compliance.  By aligning compliance with business priorities, Brisa turns regulatory management into a strategic investment: one that drives growth rather than restricts it.  5. The Multiplier Effect of Efficiency  Regulatory efficiency produces a ripple effect across the entire healthcare ecosystem:  Manufacturers gain faster access and reduced costs;  Distributors benefit from predictability and portfolio expansion;  Healthcare providers access new technologies sooner;  Patients receive safer, more advanced care faster;  Regulators strengthen oversight through clearer data and governance.  In the long term, this synergy supports a more competitive, innovative, and sustainable healthcare market.  6. Conclusion: Efficiency as a Shared Responsibility  Regulatory efficiency is not achieved by speed alone; it is about balance. It requires collaboration between regulators, industry, and consulting partners who share the same purpose: ensuring safety while enabling innovation.  At Brisa, we believe that when regulation works efficiently, everyone benefits from global manufacturers to local healthcare systems and, ultimately, to the patients whose lives depend on timely access to innovation. Because in healthcare, e  Find out more about BPO in RA!   *Budget for registration ownership transfer, Market Access Strategy, and BPO in RA services for your company: www.brisa.com.br  

In the highly regulated world of healthcare, success depends not only on technical expertise, but on trust, transparency, and partnership.  Manufacturers, distributors, regulatory agencies, and consultants each play a critical role in ensuring that innovative medical technologies reach patients safely and efficiently. At Brisa, we believe that lasting success in the Brazilian healthcare market is built through long-term partnerships, not transactional relationships.  Our approach combines deep regulatory knowledge with a collaborative mindset, turning compliance into connection and complexity into opportunity.  1. The Importance of Collaboration in Healthcare  The healthcare value chain is increasingly interconnected.  A single medical device’s journey involves dozens of stakeholders, from engineers and clinical evaluators to importers, regulators, and end users. Without collaboration, that chain becomes fragmented. With collaboration, it becomes a living ecosystem, capable of adapting, sharing knowledge, and creating collective value.  For international manufacturers entering Brazil, collaboration with the right local partner is the difference between market entry and market success. A strong partnership ensures alignment across regulatory, logistical, and commercial fronts, resulting in faster access, reduced risk, and higher trust among all players involved.  2. Partnership as a Strategic Advantage  In a sector defined by regulatory rigor and constant evolution, long-term partnerships provide stability. They create a framework for shared learning, joint problem-solving, and continuous improvement.  At Brisa, we act as more than a regulatory consultant. We become an extension of our clients’ teams, helping them make informed decisions, anticipate regulatory changes, and build strategies for sustainable growth. This long-term vision enables manufacturers to focus on innovation, while Brisa ensures that every step, from registration to distribution, operates smoothly and in full compliance.  3. The Brisa Ecosystem: Connecting Expertise and Execution  Our integrated model is designed to unite all aspects of market access under one collaborative structure. Within the Brisa ecosystem, we combine:  Regulatory consulting, ensuring compliance with Anvisa and international standards.  Legal representation, acting as a trusted partner for foreign manufacturers.  Importation and logistics, optimizing cost, timing, and tax efficiency.  Strategic distribution networks, linking products to healthcare providers and buyers across Brazil.  This ecosystem allows information to flow transparently between stakeholders, eliminating silos and ensuring that innovation moves seamlessly from concept to clinic.  4. Trust and Transparency: The Foundation of Every Partnership  Every partnership we build at Brisa is rooted in trust and transparency. Our clients have full visibility of their regulatory and operational processes, supported by clear governance and open communication.  We believe that trust is not declared; it’s demonstrated. It’s built through consistent delivery, reliability, and the ability to transform challenges into measurable results. That’s why many of our international clients see Brisa not only as a service provider but as a strategic ally, one that understands their goals and shares their commitment to excellence.  5. From Partnership to Shared Growth  True partnership goes beyond contracts. It means growing together, adapting together, and learning from each success and challenge.  In healthcare, where innovation evolves faster than regulation, shared growth ensures agility. It allows companies and consultants to co-create strategies that anticipate change rather than react to it. At Brisa, we’re proud to have built long-standing relationships based on mutual respect and a shared mission: to connect global innovation with Brazilian healthcare needs, responsibly and sustainably.  6. Conclusion: Collaboration as the Future of Healthcare  The future of healthcare will be collaborative. As technologies become more complex and global, no single organization can succeed in isolation.  At Brisa, our approach is simple but powerful: partnership over transaction, collaboration over competition, and trust over convenience. Because when we work together, across borders, disciplines, and systems, innovation moves faster, access becomes broader, and patient outcomes improve.  That’s the Brisa way: partnership with purpose.  Find out more about BPO in RA!   *Budget for registration ownership transfer, Market Access Strategy, and BPO in RA services for your company: www.brisa.com.br